GLP-3 retatrutide cost depends on vial size, vendor, and purity. Retatrutide is not FDA-approved, so pricing comes from research chemical suppliers.
There is no official GLP-3 retatrutide cost in the United States, because retatrutide is an investigational drug with no FDA approval and no retail price. What buyers actually pay is a research-supplier price for lyophilized vials labeled for laboratory use, and those listings usually run from about $50 for a 5 mg vial to more than $400 for a 30 mg vial. That works out to roughly $7 to $18 per milligram, with purity, vial size, and vendor reputation driving most of the spread.
Retatrutide is not FDA-approved for human use, so any price attached to it is a research-chemical price rather than a pharmacy or insurance price.
Why There Is No Published Price for Retatrutide
Retatrutide is a triple agonist that targets GIP, GLP-1, and glucagon receptors. It is still being studied in clinical trials, which means no manufacturer has set a list price, no wholesaler distributes it, and no pharmacy can dispense it.
The question is retatrutide a glp-3 comes up constantly, and the honest answer is that "GLP-3" is community shorthand rather than an official drug class. A related question, is glp rt the same as retatrutide, usually comes from the same confusion over nicknames — both labels point to one investigational molecule.
Because there is no approved product, there is also no insurance coverage, no manufacturer coupon, and no patient assistance program for retatrutide.
Typical Research Vial Prices
Online research suppliers publish prices per vial, and the pattern is consistent: larger vials cost less per milligram. The table below reflects ranges commonly seen across US-facing vendors.
| Vial size | Typical price | Cost per mg | Notes |
|---|---|---|---|
| 5 mg | $50–$90 | $10–$18 | Smallest entry point, highest per-mg cost |
| 10 mg | $80–$160 | $8–$16 | Most common single-vial listing |
| 15 mg | $120–$220 | $8–$15 | Mid-range option |
| 20 mg | $150–$280 | $7.50–$14 | Better value if a protocol runs long |
| 30 mg | $220–$400 | $7–$13 | Lowest per-mg pricing, largest upfront spend |
These are listing prices, not verified transaction prices. Vendors adjust them often, and a price that looks unusually low is frequently a sign of untested or underdosed product.
What Actually Drives the Price
- Third-party testing. Vials with a recent certificate of analysis from an independent lab cost more, because testing adds roughly $100 to $300 per batch.
- Vial size. Manufacturing, packaging, and shipping costs do not scale linearly, so a 30 mg vial is not six times the price of a 5 mg vial.
- Purification. Higher purity requires more synthesis and chromatography work, which shows up in the price.
- Vendor markup. Domestic US suppliers typically charge more than overseas sellers, largely for faster shipping and easier payment.
- Bundle pricing. Buying five or ten vials at once often cuts the per-mg price by 20% to 35%.
Retatrutide Cost Per Month in Research Math
When people calculate retatrutide cost per month, they start with total milligrams consumed rather than the number of vials. The arithmetic is simple: total milligrams multiplied by cost per milligram.
For example, a protocol that consumes 8 mg in a month at $10 per milligram costs about $80. The same 8 mg at $15 per milligram costs about $120. Shipping, bacteriostatic water, and syringes push the real monthly figure higher.
| Option | Regulatory status | Typical monthly cost |
|---|---|---|
| Retatrutide research vials | Not FDA-approved | About $80–$300 in research supply |
| Semaglutide (Wegovy) | FDA-approved | Roughly $1,349 list |
| Tirzepatide (Zepbound) | FDA-approved | Roughly $1,059 list |
| Compounded semaglutide | Not FDA-approved | Varies widely, often $150–$400 |
Those figures are list prices or market ranges that change frequently, and insurance coverage alters them substantially.
Reconstitution Supplies and Hidden Costs
The vial is only part of the total. A bac water for retatrutide setup, syringes, alcohol swabs, and a sharps container typically add $10 to $30 to a first order.
Dilution volume does not change what the peptide costs, but it changes how many draws come out of one vial. If you are researching how to mix retatrutide with bac water, sterile technique matters more than speed: push the water slowly down the side of the vial, swirl instead of shaking, and keep the reconstituted vial refrigerated.
A vial ruined by contamination is the most expensive outcome of all, because it means paying twice for the same milligrams.
Warning Signs in Retatrutide Pricing
- A price far below the $7 per milligram floor, which usually signals underdosed or mislabeled product.
- No certificate of analysis, or a COA that does not match the batch number printed on the vial.
- Marketing that promises weight loss results, a claim no legitimate research supplier makes.
- No shipping or payment transparency, or pressure to pay through untraceable methods.
Retatrutide has not been proven safe or effective for human use, and no clinician can prescribe it. Anyone considering an investigational peptide should speak with a licensed healthcare professional first.
The bottom line: the GLP-3 retatrutide cost you see online is a research-supplier number that moves with vial size, purity, and testing, not a regulated drug price. Budget roughly $7 to $18 per milligram, expect supplies and shipping on top, and treat any vendor claiming otherwise with suspicion.
Frequently Asked Questions
How much does retatrutide cost per month?
Because retatrutide is not FDA-approved, there is no official monthly price. Research vials typically sell for $7 to $18 per milligram, so a month that consumes 8 mg runs roughly $80 to $145 before supplies and shipping.
Is GLP-3 the same thing as retatrutide?
GLP-3 is informal shorthand sometimes used for triple agonists like retatrutide, and it is not an FDA-recognized drug class. Retatrutide itself is an investigational GIP, GLP-1, and glucagon triple agonist with no approved product on the market.
Why is retatrutide cheaper than Wegovy or Zepbound?
Wegovy and Zepbound are FDA-approved medicines whose list prices reflect clinical trials, regulatory review, and commercial manufacturing. Retatrutide vials are sold as unapproved research chemicals with no clinical validation for human use, so the price reflects raw peptide and vendor markup rather than regulated pharmaceutical development.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.